Effect of age on the association of obstructive sleep apnea with metabolic syndrome among obese and nonobese adults
- PMID: 40160006
- PMCID: PMC12320680
- DOI: 10.5664/jcsm.11698
Effect of age on the association of obstructive sleep apnea with metabolic syndrome among obese and nonobese adults
Abstract
Study objectives: It has been described a bi-directional association between obstructive sleep apnea (OSA) and metabolic syndrome (MetS), both promoting atherosclerosis and cardiovascular disease. Given that cardiometabolic comorbidities associated with OSA tend to diminish with age, in this study we examined whether the association of OSA with MetS is modified by age and body weight.
Methods: We studied 1,741 adults from the Penn State Adult Cohort (age 20-88 years) who underwent a 1-night polysomnography, clinical history, and physical examination in a cross-sectional design. The presence of OSA was defined as an apnea-hypopnea index ≥ 15 events/h. Outcome variables include the 5 MetS components (obesity [≥ 30kg/m2], hypertension [≥ 130/85 mm Hg], hyperglycemia [fasting blood sugar (FBS) ≥ 100 mg/dL], hypercholesterolemia [≥ 200 mg/dL], and hypertriglyceridemia [≥ 150 mg/dL]). Logistic regression models examined the association of OSA with MetS components adjusting for confounders.
Results: There was a significant interaction between OSA and age on MetS. In young and middle-aged individuals (< 60 years old) but not in older individuals, OSA was significantly associated with MetS and its individual components, ie, hypertension (odds ratio [OR] = 3.85, 95% confidence interval [CI] = 1.95-7.63), hyperglycemia (OR = 5.62, 95% CI = 2.74-11.53), hypercholesterolemia (OR = 5.99, 95% CI = 2.36-15.21), and hypertriglyceridemia (OR = 4.75, 95% CI = 2.30-9.90). The association of OSA with body mass index was stronger in the young and middle-aged vs older group (OR = 6.03, 95% CI = 3.08-11.78 vs 2.47, 95% CI = 1.23-4.94, respectively). Similar age-related modifications were observed in nonobese individuals.
Conclusions: The strong association of OSA with MetS in young and middle-aged obese and nonobese adults, but not in older adults, suggests that MetS is key to the pathogenesis of OSA in young and middle-aged adults and should be a treatment priority.
Citation: Pejovic S, Vgontzas AN, Fernandez-Mendoza J, He F, Li Y, Bixler EO. Effect of age on the association of obstructive sleep apnea with metabolic syndrome among obese and nonobese adults. J Clin Sleep Med. 2025;21(8):1371-1378.
Keywords: cohort study; metabolic syndrome; sleep apnea; sleep-disordered breathing.
© 2025 American Academy of Sleep Medicine.
Conflict of interest statement
All authors have seen and approved the manuscript. Work was performed at the Sleep Research & Treatment Center, Penn State Health Milton S. Hershey Medical Center, The Pennsylvania State University, College of Medicine, Hershey, PA. This study was supported partially by National Heart Lung and Blood Institute Grants ROl HL40916 (principal investigator [PI] E. O. Bixler, co-investigator [Co-I] A. N. Vgontzas) and HLS193 (PI E. O. Bixler, Co-I A. N. Vgontzas). The other authors of the study report no financial support. The authors report no conflicts of interest.
Similar articles
-
Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.Cochrane Database Syst Rev. 2015 Jul 14;(7):CD011090. doi: 10.1002/14651858.CD011090.pub2. Cochrane Database Syst Rev. 2015. PMID: 26171909
-
Mild-to-moderate obstructive sleep apnea and mortality risk in a general population sample: The modifying effect of age and cardiovascular/cerebrovascular comorbidity.J Sleep Res. 2024 May;33(3):e13944. doi: 10.1111/jsr.13944. Epub 2023 May 19. J Sleep Res. 2024. PMID: 37203593
-
Relationship between obstructive sleep apnea and metabolic syndrome based on the NHANES and mendelian randomization study.Eur Arch Otorhinolaryngol. 2025 May;282(5):2471-2484. doi: 10.1007/s00405-025-09209-y. Epub 2025 Mar 26. Eur Arch Otorhinolaryngol. 2025. PMID: 40140010
-
Drug therapy for obstructive sleep apnoea in adults.Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003002. doi: 10.1002/14651858.CD003002.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2013 May 31;(5):CD003002. doi: 10.1002/14651858.CD003002.pub3. PMID: 16625567 Updated.
-
Tonsillectomy or adenotonsillectomy versus non-surgical management for obstructive sleep-disordered breathing in children.Cochrane Database Syst Rev. 2015 Oct 14;2015(10):CD011165. doi: 10.1002/14651858.CD011165.pub2. Cochrane Database Syst Rev. 2015. PMID: 26465274 Free PMC article.
Cited by
-
Age matters: the differential impact of OSA on metabolic health by age group.J Clin Sleep Med. 2025 Aug 1;21(8):1335-1336. doi: 10.5664/jcsm.11796. J Clin Sleep Med. 2025. PMID: 40471082 Free PMC article. No abstract available.
References
-
- Vgontzas AN , Bixler EO , Chrousos GP . Sleep apnea is a manifestation of the metabolic syndrome . Sleep Med Rev. 2005. ; 9 ( 3 ): 211 – 224 . - PubMed
-
- Young T , Palta M , Dempsey J , Skatrud J , Weber S , Badr S . The occurrence of sleep-disordered breathing among middle-aged adults . N Engl J Med. 1993. ; 328 ( 17 ): 1230 – 1235 . - PubMed
-
- Bixler EO , Vgontzas AN , Ten Have T , Tyson K , Kales A . Effects of age on sleep apnea in men: I. Prevalence and severity . Am J Respir Crit Care Med. 1998. ; 157 ( 1 ): 144 – 148 . - PubMed
-
- Young T , Peppard P , Palta M , et al . Population-based study of sleep-disordered breathing as a risk factor for hypertension . Arch Intern Med. 1997. ; 157 ( 15 ): 1746 – 1752 . - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical